PPARG and neoplasm: Factors affecting drug efficacy could include compound-specific effects, the necessity of Pparγ activation or other targets, the tumor stage at the time of drug exposure, the age of the patient, and finally the influence of TZDs on cancer cell paracrine activity (195–197).